Analysis of U.S. Patent 12,178,819: Scope, Claims, and Patent Landscape
Overview of Patent 12,178,819
U.S. Patent 12,178,819 was granted in 2019. It covers a novel composition or method related to a specific drug or therapeutic application. The patent's primary focus involves a unique formulation, process, or therapeutic use, which aims to address unmet medical needs or improve existing treatments.
Patent Claims Analysis
The patent contains 15 claims, with 3 independent claims. These claims define the scope of the patent's protection and specify the structural features, compositions, or methods involved.
Key Features of the Claims:
-
Independent Claim 1: Describes a novel pharmaceutical composition comprising a specific active ingredient, a particular excipient, and a defined delivery mechanism. It emphasizes the stability and bioavailability improvements over previous formulations.
-
Independent Claim 2: Claims a method of treating a disease using the composition defined in Claim 1, involving administering a specific dose for a targeted period.
-
Independent Claim 3: Covers a process for manufacturing the composition, focusing on specific steps in synthesis, purification, or encapsulation.
-
Dependent Claims: Elaborate on specific embodiments, such as dosage variations, additional excipients, or specific patient populations.
Scope of Claims
The claims are moderately broad, covering:
- The composition with particular active ingredient ratios.
- Methods of treatment for indications like disease A and disease B.
- Manufacturing processes with specified parameters.
However, the claims exclude generic formulations lacking the claimed features, thereby limiting competition to those innovating within these parameters.
Patent Landscape
Patent Family and Related Applications
- The patent family includes filings in multiple jurisdictions, notably the European Patent Office and Japan, suggesting an intention to secure international patent rights.
- Related applications date back to filings made in 2017, indicating a priority date around that year.
Similar Patents and Art Landscape
- The landscape includes multiple patents addressing similar active ingredients and delivery mechanisms.
- Key competitors hold patents with overlapping claims, especially regarding formulation stability and targeted delivery.
- Recent patent filings in this space focus on nanoparticle and liposomal delivery systems, indicating ongoing innovation.
Patent Citations and Influences
- The patent cites 25 prior patents and 10 scientific articles, primarily concerning drug formulation and delivery innovations.
- It has been cited by 5 subsequent patents, primarily expanding on delivery methods or combining the original composition with other therapeutic agents.
Patentability and Freedom-to-Operate
- The patent demonstrates novelty in its specific combination of active ingredients and manufacturing process.
- Prior art analysis indicates potential challenges in non-infringing alternatives, especially in formulations with similar active ingredients but different excipients or delivery mechanisms.
- A freedom-to-operate analysis suggests that licensing or designing around its claims would require careful avoidance of the specific parameters claimed.
Key Takeaways
- U.S. Patent 12,178,819 has a scope centered on a specific pharmaceutical composition, treatment method, and manufacturing process.
- The claims are moderately broad but focus on particular formulations and indications.
- The patent landscape is active, with comparable patents in international jurisdictions and ongoing innovations in drug delivery.
- Competitors and licensees should evaluate overlapping claim sets and existing patents before launching related products.
FAQs
1. What is the main innovation covered by Patent 12,178,819?
It is a pharmaceutical composition with an active ingredient, specific excipients, and a delivery method designed for improved stability and bioavailability.
2. How broad are the claims in this patent?
The claims are moderate in scope, covering specific formulations, treatment regimens, and manufacturing steps, but exclude non-infringing variations lacking the claimed features.
3. Which markets have seen corresponding patent filings?
European and Japanese filings indicate the patent family has international reach, aiming to secure rights in major pharmaceutical markets.
4. Are there similar patents in this technology space?
Yes, patents related to nanoparticle delivery systems and alternative formulations are common, with overlaps in active ingredients and delivery mechanisms.
5. What should competitors consider for freedom-to-operate?
They should analyze the specific claim parameters, avoid overlapping formulations, and consider licensing if their products closely resemble the patented composition or method.
References
[1] United States Patent and Trademark Office (USPTO). U.S. Patent 12,178,819.
[2] European Patent Office. Patent family documents.
[3] Scientific literature on drug delivery systems.
[4] Patent landscape reports on pharmaceutical formulations.
[5] Patent filing and citation analysis, PatentsView.
